The Dividend Yield as of November 2024 (TTM) for Phathom Pharmaceuticals, Inc. (PHAT) is 0%

According to Phathom Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Phathom Pharmaceuticals, Inc. (PHAT) Historical Dividend Yield (quarterly & annually)

How has PHAT Dividend Yield performed in the past?

The mean historical Dividend Yield of Phathom Pharmaceuticals, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), PHAT's Dividend Yield was at its highest in in the March 2018 quarter at 0%. The Dividend Yield was at its lowest in in the March 2018 quarter at 0%.

Phathom Pharmaceuticals, Inc. (PHAT) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Phathom Pharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Phathom Pharmaceuticals, Inc. (PHAT) Average Dividend Yield

How has PHAT Dividend Yield performed in the past?

The current Dividend Yield of Phathom Pharmaceuticals, Inc. (PHAT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Phathom Pharmaceuticals, Inc. (PHAT) Dividend Yield vs. Peers

How is PHAT’s Dividend Yield compared to its peers?

Phathom Pharmaceuticals, Inc.’s Dividend Yield is less than Day One Biopharmaceuticals, Inc. (0%), less than Blueprint Medicines Corporation (0%), less than Lyra Therapeutics, Inc. (0%), less than Cullinan Oncology, Inc. (0%), less than Acumen Pharmaceuticals, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Inozyme Pharma, Inc. (0%), less than VectivBio Holding AG (0%), less than Kiniksa Pharmaceuticals, Ltd. (0%), less than Structure Therapeutics Inc. (0%), less than Karuna Therapeutics, Inc. (0%), less than Immix Biopharma, Inc. (0%), less than CNS Pharmaceuticals, Inc. (0%), less than Hepion Pharmaceuticals, Inc. (0%), less than Freeline Therapeutics Holdings plc (0%), less than AVROBIO, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than Amylyx Pharmaceuticals, Inc. (0%),

Build a custom stock screener for Phathom Pharmaceuticals, Inc. (PHAT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Phathom Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Phathom Pharmaceuticals, Inc. (PHAT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Phathom Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.